Biohit

Biohit Oyj is a Finnish biotechnology company that develops and manufactures diagnostic tests and analysis systems for research institutions and the healthcare industry globally. The company's product portfolio includes various diagnostic tests, such as the GastroPanel for stomach disease diagnosis, Biohit Active B12 for measuring active vitamin B12 levels, and tests for detecting fecal occult blood, lactose intolerance, celiac disease, and H. pylori infections. Additionally, Biohit offers products that bind carcinogenic acetaldehyde, including Acetium capsules and lozenges, aimed at individuals with low-acid or anacidic stomachs. The company also provides monoclonal antibodies for research in cellular pathology, neurobiology, and oncology, as well as laboratory services and automated immunoassay analyzers. Founded in 1988 and headquartered in Helsinki, Finland, Biohit aims to enhance the quality of life by promoting early diagnosis and preventing serious illnesses. The company operates subsidiaries in Italy and the United Kingdom.